Influência do emprego de albumina humana sobre a função pulmonar de pacientes submetidos à cirurgia cardíaca com circulação extracorpórea

Hugo Leonardo de Moura Luz; Mara Regina Guerreiro Moreira; José Otávio Costa Auler Júnior; Maria José Carvalho Carmona

doi:10.1590/S0034-70942004000400009

Scientific Article

Influência do emprego de albumina humana sobre a função pulmonar de pacientes submetidos à cirurgia cardíaca com circulação extracorpórea

Influence of human albumin on pulmonary function of patients submitted to heart surgery with cardiopulmonary bypass

Hugo Leonardo de Moura Luz; Mara Regina Guerreiro Moreira; José Otávio Costa Auler Júnior; Maria José Carvalho Carmona

http://dx.doi.org/10.1590/S0034-70942004000400009 Braz J Anesthesiol, vol.54, n4, p.532-541, 2004

PDF

Downloads: 1

Resumo

JUSTIFICATIVA E OBJETIVOS: O emprego de albumina humana em cirurgias cardíacas com circulação extracorpórea (CEC) é controverso, embora seja procedimento utilizado com freqüência. O objetivo deste estudo foi analisar os efeitos do uso da albumina humana sobre a função de troca gasosa pulmonar em pacientes submetidos à cirurgia de revascularização do miocárdio com CEC. MÉTODO: Vinte pacientes foram divididos aleatoriamente em dois grupos, em relação à solução utilizada no perfusato da CEC: no grupo controle (n = 10) utilizou-se diluição total com solução de Ringer com lactato, também utilizada na hidratação intra-operatória. No grupo albumina (n = 10) foram adicionados 20 g de albumina humana ao perfusato da CEC ou como parte da hidratação no período pós-CEC. A relação entre a pressão arterial de oxigênio e sua fração inspirada (PaO2/FiO2), o gradiente alvéolo-arterial de oxigênio (GA-aO2) e o shunt pulmonar foram avaliados após a indução anestésica, ao final da cirurgia e no primeiro e segundo dias de pós-operatório e comparados nos dois grupos através de Análise de Variância para medidas repetidas (p < 0,05). RESULTADOS: Os dois grupos estudados foram comparáveis em relação às características pré-operatórias, tempo de CEC e de cirurgia. Os valores de PaO2/FiO2, GA-aO2 e shunt pulmonar não mostraram diferença estatisticamente significativas entre os grupos. CONCLUSÕES: Este estudo demonstrou que a adição de albumina humana no perfusato da CEC ou como parte da hidratação intra-operatória em cirurgia revascularização do miocárdio com circulação extracorpórea não resultou em benefícios para a função pulmonar. Como a albumina apresenta custo elevado, o seu uso rotineiro não está justificado.

Palavras-chave

CIRURGIA, CIRURGIA, SISTEMA RESPIRATÓRIO, VOLEMIA

Abstract

BACKGROUND AND OBJECTIVES: Human albumin in heart surgeries with cardiopulmonary bypass (CPB) is controversial although being a frequent procedure. This study aimed at evaluating the effects of human albumin on pulmonary gaseous exchange function in patients submitted to myocardial revascularization with CPB. METHODS: Participated in this study 20 patients randomly distributed in two groups according to CPB perfusate solution: control group (n = 10) - total dilution with lactated Ringer's solution, also used for intraoperative hydration; albumin group (n = 10) - 20 g human albumin were added to CPB perfusate or as part of post-CPB hydration. Oxygen arterial tension and inspired fraction ratio (PaO2/FiO2), oxygen alveolar-arterial gradient (GA-aO2) and pulmonary shunt were evaluated after anesthetic induction, at surgery completion and in the first and second postoperative day and were compared in both groups by Analysis of Variance for repeated measures (p < 0.05). RESULTS: Both groups were comparable in preoperative characteristics, CPB and surgery duration. PaO2/FiO2, GA-aO2 and pulmonary shunt values were not statistically different between groups. CONCLUSIONS: Our study has shown that the addition of human albumin to CPB perfusate or as part of intraoperative hydration during myocardial revascularization with cardiopulmonary bypass has not improved pulmonary function. Since albumin is expensive, its routine use is not justified.

Keywords

RESPIRATORY SYSTEM, SURGERY, SURGERY, VOLEMIA

References

Myers GJ. A comparative review of crystalloid, albumin, pentastarch, and hetastarch as perfusate for cardiopulmonary bypass. J Extra-Corporeal Technol. 1997;29:30-35.

Hammermeister KE, Burchfiel C, Johnson R. Identification of patients at greatest risk for developing major complications at cardiac surgery. Circulation. 1990;82:380-389.

Mangano DT. Perioperative cardiac morbidity. Anesthesiology. 1990;72:153-184.

Higgins TL, Estafanous FG, Loop FD. Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients: A clinical severity score. JAMA. 1992;267:2344-2348.

Griffel MI, Kaufman BS. Pharmacology of colloids and crystalloids. Crit Care Clin. 1992;8:235-253.

Hachenberg T, Tenling A, Rothen HU. Thoracic intravascular and extravascular fluid volumes in cardiac surgical patients. Anesthesiology. 1993;79:976-984.

Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 1993;55:552-559.

Gallagher JD, Moore RA, Kerns D. Effects of colloid or crystalloid administration on pulmonary extravascular water in the postoperative period after coronary artery bypass grafting. Anesth Analg. 1985;64:753-758.

Shapira N, Zabatino SM, Ahmed S. Determinants of pulmonary function in patients undergoing coronary bypass operations. Ann Thorac Surg. 1990;50:268-273.

Hoeft A, Korb H, Mehlhorn U. Priming of cardiopulmonary bypass with human albumin or Ringer lactate: effect on colloid osmotic pressure and extravascular lung. Br J Anaesth. 1991;66:73-80.

Buhre W, Hoeft A, Schorn B. Acute effect of mitral valve replacement on extravascular lung water in patients receiving colloid or crystalloid priming of cardiopulmonary bypass. Br J Anaesth. 1997;79:311-316.

Jenkins IR, Curtis AP. The combinations of mannitol and albumin in the priming solution reduces positive intraoperative fluid balance during cardiopulmonary bypass. Perfusion. 1995;10:301-305.

Louagie Y, Gonzalez E, Jamart J. Postcardiopulmonary bypass lung edema. A preventable complication? Chest. 1993;103:86-95.

Weaver DW, Ledgerwood AM, Lucas CE. Pulmonary effects of albumin resuscitation for severe hypovolemic shock. Arch Surg. 1978;113:387-392.

Sade RM, Stroud MR, Crawford Jr FA. A prospective randomized study of hydroxyethyl starch, albumin, and lactated Ringer's solution as priming fluid for cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1985;89:713-722.

Messent M, Sinclair DG, Quinlan GJ. Pulmonary vascular permeability after cardiopulmonary bypass and its relationship to oxidative stress. Crit Care Med. 1997;25:425-429.

Ratliff NB, Young Jr WG, Hackel DB. Pulmonary injury secondary to extracorporeal circulation. An ultrastructural study. J Thorac Cardiovasc Surg. 1973;65:425-432.

Boks RH, Herwerden LA, Takkenberg JJ. Is the use of albumin in colloid prime solution of cardiopulmonary bypass circuit justified?. Ann Thorac Surg. 2001;72:850-853.

Tigchelaar I, Gallandat Huet RC, Korsten J. Hemostatic effects of three colloid plasma substitutes for priming solution in cardiopulmonary bypass. Eur J Cardiothorac Surg. 1997;11:626-632.

Engelman DT, Adams DH, Byrne JG. Impact of body mass index and albumin on morbidity and mortality after cardiac surgery. J Thorac Cardiovasc Surg. 1999;118:866-873.

McClelland DB. Safety of human albumin as a constituent of biologic therapeutic products. Transfusion. 1998;38:690-699.

Influência do emprego de albumina humana sobre a função pulmonar de pacientes submetidos à cirurgia cardíaca com circulação extracorpórea

Influence of human albumin on pulmonary function of patients submitted to heart surgery with cardiopulmonary bypass

Hugo Leonardo de Moura Luz; Mara Regina Guerreiro Moreira; José Otávio Costa Auler Júnior; Maria José Carvalho Carmona

Resumo

Palavras-chave

Abstract

Keywords

References

Links

Share

Braz J Anesthesiol